Suppr超能文献

终末期肝病不同血流动力学模式的临床特征及预后:一项回顾性队列分析

Clinical Characteristics and Outcomes Associated With Distinct Hemodynamic Patterns in End-stage Liver Disease: A Retrospective Cohort Analysis.

作者信息

Wattanachayakul Phuuwadith, Martinez Manzano Jose M, Geller Andrew, Malin John, Leguizamon Raul, John Tara A, Khan Rasha, McLaren Ian, Prendergast Alexander, Jarrett Simone A, Sarvottam Kumar, Lo Kevin B

机构信息

Department of Medicine, Jefferson Einstein Hospital, Sidney Kimmel College of Medicine, Philadelphia, PA, USA.

Division of Pulmonary and Critical Care, Department of Medicine, Jefferson Einstein Hospital, Sidney Kimmel College of Medicine, Philadelphia, PA, USA.

出版信息

J Clin Exp Hepatol. 2024 Nov-Dec;14(6):101470. doi: 10.1016/j.jceh.2024.101470. Epub 2024 Jun 20.

Abstract

INTRODUCTION

Despite advances in the diagnosis and therapeutics strategies for pulmonary hypertension (PH) in patients with end-stage liver disease (ESLD), the impact of hemodynamic patterns among ESLD patients identified through right heart catheterization (RHC) on clinical outcomes remains poorly understood.

METHODS

This single-center retrospective cohort study identified patients diagnosed with ESLD who underwent RHC from August 2018 to June 2023. Demographic and clinical data, including comorbidities, transthoracic echocardiography, and RHC findings, were obtained. Our outcomes of interest were all-cause mortality and the chance of receiving orthotopic liver transplantation (OLT) within a year after RHC. Kaplan-Meier with log-rank test was employed to generate survival curves.

RESULTS

We identified 415 ESLD patients with the RHC results. The median (IQR) age was 59 years (52-66), and 62% were male. Caucasians accounted for 43%, followed by African Americans (30%). Up to 89% had a diagnosis of portal hypertension. Median MELD-Na score was 30 (19-36). The etiology of ESLD was mainly from alcohol use (55%). Patients were classified based on RHC results as pre-capillary PH (19%), post-capillary PH (28%), and non-PH (53%) groups. Overall, one-year mortality post-RHC was 22%, with no significant difference in mortality regardless of hemodynamic group. However, the pre-capillary PH group was less likely to receive OLT compared to other groups ( < 0.001).

CONCLUSION

We observed no difference in all-cause mortality among hemodynamic groups. However, pre-capillary PH group were less likely to undergo OLT compared to others. Further investigations are necessary to determine how this should be addressed in clinical practice.

摘要

引言

尽管终末期肝病(ESLD)患者肺动脉高压(PH)的诊断和治疗策略取得了进展,但通过右心导管检查(RHC)确定的ESLD患者血流动力学模式对临床结局的影响仍知之甚少。

方法

这项单中心回顾性队列研究确定了2018年8月至2023年6月期间接受RHC的ESLD诊断患者。获取了人口统计学和临床数据,包括合并症、经胸超声心动图和RHC结果。我们感兴趣的结局是全因死亡率和RHC后一年内接受原位肝移植(OLT)的机会。采用Kaplan-Meier法和对数秩检验生成生存曲线。

结果

我们确定了415例有RHC结果的ESLD患者。中位(IQR)年龄为59岁(52-66岁),62%为男性。白种人占43%,其次是非裔美国人(30%)。高达89%的患者诊断为门静脉高压。中位MELD-Na评分为30(19-36)。ESLD的病因主要来自酒精使用(55%)。根据RHC结果,患者分为毛细血管前性PH组(19%)、毛细血管后性PH组(28%)和非PH组(5)。总体而言,RHC后一年的死亡率为22%,无论血流动力学组如何,死亡率均无显著差异。然而,与其他组相比,毛细血管前性PH组接受OLT的可能性较小(<0.001)。

结论

我们观察到血流动力学组之间全因死亡率无差异。然而,与其他组相比,毛细血管前性PH组接受OLT的可能性较小。需要进一步研究以确定在临床实践中应如何解决这一问题。

相似文献

本文引用的文献

1
OPTN/SRTR 2022 Annual Data Report: Liver.OPTN/SRTR 2022 年度数据报告:肝脏。
Am J Transplant. 2024 Feb;24(2S1):S176-S265. doi: 10.1016/j.ajt.2024.01.014.
2
Managing a Prospective Liver Transplant Recipient on the Waiting List.管理等待名单上的潜在肝移植受者。
J Clin Exp Hepatol. 2024 Jan-Feb;14(1):101203. doi: 10.1016/j.jceh.2023.06.003. Epub 2023 Jun 14.
3
Current clinical understanding and effectiveness of portopulmonary hypertension treatment.门肺高压治疗的当前临床认识及疗效
Front Med (Lausanne). 2023 Apr 4;10:1142836. doi: 10.3389/fmed.2023.1142836. eCollection 2023.
5
Is Liver Transplant Justified at Any MELD Score?任何终末期肝病模型(MELD)评分下进行肝移植都合理吗?
Transplantation. 2023 Mar 1;107(3):680-692. doi: 10.1097/TP.0000000000004345. Epub 2022 Oct 20.
6
Liver Transplant Outcomes in Patients With Postcapillary Pulmonary Hypertension.毛细血管后肺动脉高压患者的肝移植结局
Transplant Direct. 2022 Oct 7;8(11):e1372. doi: 10.1097/TXD.0000000000001372. eCollection 2022 Nov.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验